Roma Gianchandani is an Endocrinology/Metabolic physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 94 publications with 1,530 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8700 Beverly Blvd
West Hollywood, CA 900481804
Telephone
310-423-3870Provider last certified this registry record 2 Dec 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insulet CorporationProgram year20243 payments
- Novo Nordisk IncProgram year20237 payments
- Insulet CorporationProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
78.6%GLP-1 receptor agonist32.1%Mounjaro100%Part D<11 patientsDPP-4 inhibitor23.2%Janumet100%Part D<11 patients+ 1 more class in this area
Cardiovascular
21.4%Angiotensin receptor blocker (ARB)21.4%Losartan Potassium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework
The Journal of Clinical Endocrinology & Metabolism
2026 - Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes
Journal of Diabetes Science and Technology
2024 - Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit
Journal of Diabetes Science and Technology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Raj Makkar, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
Cristina Ferrone, MD
Cedars-Sinai Medical Center
Stephen Pandol, MD
Cedars-Sinai Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”